research use only
Cat.No.S2405
| Related Targets | CFTR CRM1 CD markers AChR Calcium Channel Sodium Channel GABA Receptor TRP Channel ATPase GluR |
|---|---|
| Other Potassium Channel Inhibitors | TRAM-34 Nicorandil ML133 HCl Hydralazine HCl Nigericin Gliquidone E-4031 dihydrochloride PAP-1 Ajmaline NS-1619 |
| Molecular Weight | 246.35 | Formula | C15H22N2O |
Storage (From the date of receipt) | |
|---|---|---|---|---|---|
| CAS No. | 6483-15-4 | Download SDF | Storage of Stock Solutions |
|
|
| Synonyms | N/A | Smiles | C1CC2CN3C(CC=CC3=O)C4C2N(C1)CCC4 | ||
|
In vitro |
DMSO
: 49 mg/mL
(198.9 mM)
Ethanol : 49 mg/mL Water : 6 mg/mL |
|
In vivo |
|||||
Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)
Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)
Calculation results:
Working concentration: mg/ml;
Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )
Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.
Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.
Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such as vortex, ultrasound or hot water bath can be used to aid dissolving.
| In vitro |
Sophocarpine exerts anti-cachectic effects by inhibiting TNF-α and IL-6 production in both RAW264.7 cells and murine primary macrophages. This compound also shows antivirus activity by inhibiting HHV-6 replication in Molt-3 cells. In addition, it is a potent blocker of HERG K+ channels with an IC50 of about 200 mM.
|
|---|---|
| In vivo |
Administration of 50 mg/kg/d sophocarpine for 5 days from the onset of cachexia does not inhibit the tumour growth but results in attenuation of cachexia symptoms in colon26 adenocarcinoma xenograft BALB/c mice. LD50: Mice 63.94 mg/kg (i.v.)
|
References |
|
Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.